Amgen Inc.'s Young Lineup Offsets Enbrel Losses With Style

Despite sagging sales for Amgen's cash cow, a handful of younger drugs kept the needle moving forward.
Those living on the Lower Thames Crossing route tell of their despair at being uprooted. from BBC News https://ift.tt/bOKISe2
0 comments:
Post a Comment